CORPORATIONS: Merck's Merger
Two of the nation's biggest drug manufacturers last week agreed to become the biggest. Directors of Merck & Co., which grossed $105.7 million and netted $8.4 million last year, and Sharp & Dohme, which netted $3.9 million on a $50.4 million gross, okayed a plan to merge. If stockholders approve, the combined company will pass Parke, Davis & Co. as the biggest U.S. maker of ethical drugs.*
The firm would take the Merck name, but Sharp & Dohme would continue to operate as a separate unit. Sharpe & Dohme shareholders seemed to be getting the best of it. They would...
Email, Password or Region is incorrect
A required form parameter was missing.
The System is currently down. Please try again in a few minutes.
Email Address is invalid
Password is blank
Most Popular »
- How Cash Keeps Poor People Poor
- E.T. Turns 30: 10 Things You Didn't Know About Our Favorite Extraterrestrial
- 15-Year-Old Creates Test for Pancreatic Cancer
- Nevada Ghosts: Rare Photos From an A-Bomb Test
- Euro Crisis: Why A Greek Exit Could Be Much Worse Than Expected
- Could a Fertility Gene Discovery Lead to New Male Contraception?
- Fourth Flesh-Eating-Bacteria Case Confirmed in Georgia, Possible Fifth
- 10 Dangerous Products You Might Have in Your Home
- Obama Stumbles? Why the President's Right to Talk About Bain
- Star Wars Turns 35: How TIME Covered the Film Phenomenon
- Researchers Probe the Potential Health Benefits of Palm Oil
- A Visit with Turkey's Controversial Religious Movement
- Feeding the Planet Without Destroying It
- Bubble on the Potomac
- Falcon's Liftoff: How a Private Firm Could Change Space Exploration
- The Fatal Flight of the Superjet 100: Why Did It Slam Into a Mountain?
- Learning That Works
- The Man Who Remade Motherhood
- Bibi's Choice
- Seoul: 10 Things to Do




